
Feature|Videos|January 9, 2025
Reflecting on the COVID-19 Pandemic Response
Lessons from the COVID-19 response highlight regulatory collaboration, research expansion, and challenges in vaccine access and preparedness.
Advertisement
Episodes in this series

A lot can be learned from the COVID-19 response, including global regulatory collaboration, de-risking pharmaceutical development, and expanding research participation. This segment covers challenges such as sustaining preparedness and addressing vaccine access inequities.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy
2
Novel Delivery Approaches of Biopharmaceuticals 2025
3
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
4
EMA Director Highlights Agency Achievements in 2025
5



